-
Mashup Score: 0
Standardizing the definition of intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC), which is a heterogeneous disease, is critical for appropriate management of patients. The International Bladder Cancer Group recommends classification of IR NMIBC tumors and personalized management bas …
Source: PubMedCategories: Dental, Latest Headlines, Onc News and JournalsTweet
-
Mashup Score: 0
Standardizing the definition of intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC), which is a heterogeneous disease, is critical for appropriate management of patients. The International Bladder Cancer Group recommends classification of IR NMIBC tumors and personalized management bas …
Source: PubMedCategories: Dental, Latest Headlines, Onc News and JournalsTweet
-
Mashup Score: 3Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial - PubMed - 9 month(s) ago
This trial confirms the superiority of the combination melphalan and prednisone plus thalidomide over melphalan and prednisone alone for prolonging survival in very elderly patients with newly diagnosed myeloma. Toxicity was acceptable.
Source: PubMedCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4
Cartesian Therapeutics and National Institute of Neurological Disorders and Stroke of the National Institutes of Health.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial - PubMed - 10 month(s) ago
Despite high choline content in egg yolks, healthy participants consuming 4 eggs daily showed no significant increase in TMAO or platelet reactivity. However, choline bitartrate supplements providing comparable total choline raised both TMAO and platelet reactivity, demonstrating that the form and s …
Source: PubMedCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 7Financial Toxicity in Oncology, More Unanswered Questions - PubMed - 10 month(s) ago
Financial Toxicity in Oncology, More Unanswered Questions
Source: PubMedCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 1Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia - PubMed - 10 month(s) ago
In patients treated in a PE, a neutropenic diet did not prevent major infection or death.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Implementation of the Trust pathway in accordance with the BOAST guidelines along with staff education has standardized the practice at our Trust. It saved approximately 63 hours of trauma theatre time for the six-month data collection period. Our findings also suggest that this has favourable outco …
Source: PubMedCategories: Latest Headlines, OrthopedicsTweet
-
Mashup Score: 1Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS - PubMed - 10 month(s) ago
This study supports the safety and tolerability of PrimeC in ALS. Biomarker analyses suggest early evidence of a biological effect. A placebo-controlled trial is required to disentangle the biomarker results from natural progression and to evaluate the efficacy of PrimeC for the treatment of ALS. Su …
Source: PubMedCategories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 2
Intensive low-density lipoprotein cholesterol lowering with a proprotein convertase subtilisin/kexin type 9 inhibitor combined with statin does not appear to increase the risk of new or worsening cancer events.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
Thoughts